Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases

Explore clinical trials studying Skin Diseases. Study availability and eligibility vary by location and protocol.

23,040 public trials 3,717 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases trial results

Recruiting

A Study of Pembrolizumab and Cryoablation in People With Breast Cancer

NCT06246968

Conditions
Breast Cancer, Breast Cancer Stage IV, Breast Diseases, +11 more
Locations
  • Memorial Sloan Kettering Cancer Center at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ) Commack, New York, United States
View Trial Details
Recruiting

Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors

NCT07334119

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adnexal Diseases, +47 more
Locations
  • The Kinghorn Cancer Centre Darlinghurst, New South Wales, Australia
  • Scientia Clinical Research Ltd Randwick, New South Wales, Australia
  • Calvary Mater Newcastle Waratah, New South Wales, Australia
  • Icon Cancer Centre South Brisbane South Brisbane, Queensland, Australia
View Trial Details
Recruiting

French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)

NCT06837454

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Investigational Site Number: 2500051 Aix-en-Provence, France
  • Investigational Site Number: 2500023 Amiens, France
  • Investigational Site Number: 2500004 Angers, France
  • Investigational Site Number: 2500017 Angers, France
View all 62 locations
View Trial Details
Recruiting

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

NCT06797635

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • UCLA Hematology/Oncology - Parkside ( Site 0021) Santa Monica, California, United States
  • Orchard Healthcare Research Inc. ( Site 0006) Skokie, Illinois, United States
  • Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana ( Site 0003) Billings, Montana, United States
  • Northwest Cancer Specialists (Compass Oncology) ( Site 8003) Tigard, Oregon, United States
View all 17 locations
View Trial Details
Recruiting

Clinical Trial to Compare Oral Isotretinoin to Standard of Care in Moderate Acne Skin of Color Patients

NCT06447480

Conditions
Acne Vulgaris, Acneiform Eruptions, Sebaceous Gland Diseases, +2 more
Locations
  • CHU de Nice - Hôpital de l'Archet Nice, Alpes-Maritimes, France
  • CHU de Bordeaux Bordeaux, Aquitaine, France
  • CHU de Nantes Nantes, Loire-Atlantique, France
  • chu de Rouen Rouen, Seine-maritime, France
View all 19 locations
View Trial Details

Related conditions